On Tuesday, Elevation Oncology Inc (NASDAQ: ELEV) opened higher 1.23% from the last session, before settling in for the closing price of $0.33. Price fluctuations for ELEV have ranged from $0.22 to $4.33 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 16.83% at the time writing. With a float of $52.07 million, this company’s outstanding shares have now reached $59.13 million.
The firm has a total of 34 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Elevation Oncology Inc (ELEV) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Elevation Oncology Inc is 12.09%, while institutional ownership is 66.18%.
Elevation Oncology Inc (ELEV) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.69% during the next five years compared to -25.69% drop over the previous five years of trading.
Elevation Oncology Inc (NASDAQ: ELEV) Trading Performance Indicators
Check out the current performance indicators for Elevation Oncology Inc (ELEV). In the past quarter, the stock posted a quick ratio of 21.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.55 in one year’s time.
Technical Analysis of Elevation Oncology Inc (ELEV)
Analysing the last 5-days average volume posted by the [Elevation Oncology Inc, ELEV], we can find that recorded value of 0.77 million was lower than the volume posted last year of 2.17 million. As of the previous 9 days, the stock’s Stochastic %D was 15.30%. Additionally, its Average True Range was 0.03.
During the past 100 days, Elevation Oncology Inc’s (ELEV) raw stochastic average was set at 15.48%, which indicates a significant decrease from 38.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 92.24% in the past 14 days, which was lower than the 128.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3750, while its 200-day Moving Average is $0.6923. Now, the first resistance to watch is $0.3460. This is followed by the second major resistance level at $0.3535. The third major resistance level sits at $0.3615. If the price goes on to break the first support level at $0.3305, it is likely to go to the next support level at $0.3225. Should the price break the second support level, the third support level stands at $0.3150.
Elevation Oncology Inc (NASDAQ: ELEV) Key Stats
There are currently 59,224K shares outstanding in the company with a market cap of 20.04 million. Presently, the company’s annual sales total 0 K according to its annual income of -44,490 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -10,440 K.
